The Ultimate Resource for Pharmaceutical SOPs and Best Practices
To define the procedure for conducting stability indicating testing of elixir formulations to monitor the active pharmaceutical ingredient (API) content and degradation profile under defined storage conditions over time, ensuring product quality and shelf-life validity.
Click to read the full article.
To define the procedure for the systematic verification of test results obtained during the quality control testing of elixir formulations to ensure data accuracy, reliability, and regulatory compliance.
Click to read the full article.
To establish a standardized procedure for the design, execution, and evaluation of shelf-life testing of elixir formulations under prescribed storage conditions in order to determine product stability and expiry dating.
Click to read the full article.
To outline the procedure for identifying, documenting, investigating, and reporting Out-of-Specification (OOS) test results observed during the Quality Control analysis of elixir products, in compliance with cGMP and regulatory standards.
Click to read the full article.
To establish a procedure for the retention of reference and stability samples of elixir formulations to support batch investigation, regulatory compliance, and quality monitoring throughout the product’s shelf-life.
Click to read the full article.
To establish a standardized procedure for distinguishing and conducting destructive and non-destructive tests on elixir formulations during in-process, finished product, and stability testing phases.
Click to read the full article.
To define the procedure for conducting line clearance before starting and after completing elixir manufacturing operations in order to prevent mix-ups, cross-contamination, and ensure equipment and area readiness.
Click to read the full article.
To define the process for identification, documentation, investigation, evaluation, and closure of deviations occurring during the manufacturing, testing, storage, or handling of elixir products in compliance with cGMP.
Click to read the full article.
To define a formal system for initiating, evaluating, approving, implementing, and reviewing changes that may impact the quality, safety, or efficacy of elixir products and associated processes in compliance with cGMP and regulatory expectations.
Click to read the full article.
To define the procedure for performing structured and systematic risk assessments during the manufacturing of elixir products to proactively identify, evaluate, and control potential risks that may impact product quality, safety, or compliance.
Click to read the full article.